Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma

Sajeev K Puri1, Lingbao Si, Chun-Yang Fan

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. purisajeevk@uams.edu

Abstract

Insights

Promoter hypermethylation of DNA repair and tumor-suppressor genes is common in head and neck cancer. Hypermethylation of multiple genes, including hMLH1, MGMT, and p16, significantly improves disease-free survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Epigenetic alterations, specifically promoter hypermethylation, are crucial in the development of head and neck squamous cell carcinoma (SCCHN).
  • This process can inactivate critical genes involved in tumor suppression and DNA repair.

Purpose of the Study:

  • To characterize the promoter methylation profiles of DNA repair genes (hMLH1, MGMT) and the tumor-suppressor gene (p16) in SCCHN.
  • To correlate these methylation profiles with clinical parameters and patient survival.

Main Methods:

  • DNA was extracted from 51 SCCHN tissue samples.
  • Methylation-specific PCR was employed to analyze promoter hypermethylation of hMLH1, MGMT, and p16 genes.

Main Results:

  • Aberrant promoter hypermethylation was detected in at least one gene in 62% of SCCHN cases.
  • Hypermethylation rates were 23% for hMLH1, 30% for MGMT, and 36% for p16.
  • Hypermethylation of two or more genes was significantly associated with improved 2-year disease-free survival (100% vs. 46%).

Conclusions:

  • Promoter hypermethylation of hMLH1, MGMT, and p16 is a frequent event in SCCHN.
  • The hypermethylation of multiple genes (2 or 3) is a significant predictor of improved disease-free survival.
  • A correlation was observed between alcohol use history and MGMT gene hypermethylation.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...